Premium
The use of pamidronate in hypertrophic pulmonary osteoarthropathy (HPOA)
Author(s) -
Speden D.,
Nicklason F.,
Francis H.,
Ward J.
Publication year - 1997
Publication title -
australian and new zealand journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.596
H-Index - 70
eISSN - 1445-5994
pISSN - 0004-8291
DOI - 10.1111/j.1445-5994.1997.tb01983.x
Subject(s) - medicine , pain control , bone pain , hypertrophic osteoarthropathy , bronchogenic carcinoma , lung , surgery , radiology , pathology
Background: Hypertrophic pulmonary osteoarthropathy (HPOA) secondary to bronchogenic carcinoma can be associated with severe, disabling pain which is not always responsive to conventional treatment. Aim: To report on the use of pamidronate to control resistant pain in HPOA in three cases. Methods: A retrospective review of reported pain, chest X‐ray and radionuclide bone scans was made. Results: Pain relief was achieved in all three cases together with reduced radiolabel uptake in two cases. Conclusions: Pamidronate appears to be an effective therapy for HPOA. Further investigation is warranted.